QIAGEN today announced proposals for its 2026 Annual General Meeting, including plans to appoint co-founder and former Chief Executive Officer Dr. Metin Colpan as Honorary Chairman, the continued ...

Johnson & Johnson grew out of an 1876 lecture by Dr. Joseph Lister on the promising results seen in his new procedure, sterile surgery. Three brothers started Johnson & Johnson, finding a factory to ...

Drug-making giant Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website on Friday, CBS News exclusively learned. The pharmaceutical ...

Johnson & Johnson has reinvented itself several times in recent years. In 2021, it was best known as the developer of a Covid vaccine. In 2023, it spun off its consumer health division to focus on ...

Investors weren't blown away by the results. The stock price is down over the last several days. After the company's first-quarter 2026 earnings report, however, the response was muted, with the stock ...

Johnson & Johnson (JNJ) raised its quarterly dividend to $1.34 per share, a 3% increase from the prior $1.30 payout. Johnson & Johnson now offers a 3.2% yield, nearly double the 1.8% healthcare sector ...

Johnson & Johnson beat first-quarter earnings expectations on Tuesday and raised its full-year forecast, as strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more than offset a ...

NEW YORK, April 17 (Reuters) - A U.S. judge has ‌rejected Bayer's (BAYGn.DE), opens new tab request for an injunction to block Johnson & Johnson's (JNJ.N), opens new tab alleged false advertising that ...

Johnson Controls expands its security ecosystem with new platform updates and integrations aimed at streamlining operations and enhancing situational awareness across commercial and enterprise ...

Healthcare giant Johnson & Johnson JNJ-0.53%decrease; red down pointing triangle reported nearly 10% revenue growth for the latest quarter on strong cancer drug sales that offset a steep decline from ...

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the company’s new psoriasis pill is quickly taking shape and signaling its ...

Raven Johnson got the last laugh against Caitlin Clark when South Carolina beat Iowa for the national championship in 2024. Ken Blaze / USA Today Network via Imagn Images Caitlin Clark and Raven ...